The current institutional shareholding score of ARS Pharmaceuticals Inc is 10.00, ranking 1 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 97.47%, representing a quarter-over-quarter increase of 9.23%. The largest institutional shareholder is Ron Baron, holding a total of 1.20M shares, representing 1.28% of shares outstanding, with 0.18% decrease in holdings.